Re: GTCB price and volume surge
>>Is it:
1. A short squeeze
2. A few acting with special information
3. Manipulation by market makers
4. Hedge fund trading (to produce a later down period)
5. Just a company with superb prospects for improving revenues
6. Other
<<
I would it’s say a combination of #5, #2, and #6.
#5: A cheap stock does not really need a compelling reason to go up, and GTCB’s valuation—even now—is cheap for a company on the verge of having an approved drug and drug platform.
#2: It’s possible that reports of a favorable plant inspection by the EMEA have leaked. It makes sense that the EMEA would want to inspect GTC’s facilities only after assuring that there were no further hang-ups with GTC’s written materials. Given that GTC submitted answers to the EMEA’s questions on July 6, it’s plausible that the inspection would have taken place within the past week or so.
#6. One or two institutional investors deciding that the time is right to jump on board could explain most or all of the price action.
Dew
News 
Market Data 
Discover 
